Posts in tag

PBS


Guild national president Trent Twomey talks about his fight against postcode healthcare, his views on the 7CPA, pharmacy’s  COVID vaccination future and professional services expansion   AJP: Are you pleased to …

The Health Minister has highlighted new PBS listings from Monday, March 1, including drugs to treat MS, asthma and diabetes From March 1, Zeposia and Atecture Breezhaler will be listed …

What are the ten most commonly dispensed, and the ten most expensive drugs on the PBS at the moment?  A drug used to treat eye conditions such as macular degeneration …

Low-dose Xarelto has been listed on the PBS in combination with aspirin, for the prevention of major cardiovascular events in high-risk patients While pharmacists have been familiar with Xarelto (rivaroxaban) …

Questions over the price of private prescriptions due to “commercial decisions by the pharmacist” as Senate tackles the question of medicine shortages Federal Senators questioned Department of Health officials on …

New medicine options approved after problems hit supply of depression treatments  The Therapeutic Goods Administration has approved new overseas options after problems were revealed regarding the availability of a couple …

Pharmacy leaders welcomed the end of World War II in our August 1945 issue, but a war of words was building over the government’s Pharmaceutical Benefits bill Pharmacy leaders expressed …

The next batch of medicines to undergo price disclosure reductions has been revealed The PBS has released the list of medicines that are to be included in the October 2020 …

PBS issues new claiming advice on opioid combinations as listing changes take effect From yesterday (1 June 2020) Pharmaceutical Benefits Scheme (PBS) listings have changed for opioid products.  The PBS …

Government moves to temporarily ease PBS authority restrictions during pandemic crisis The Australian Government is implementing a temporary measure that allows flexibility around PBS restrictions for eligible PBS medicines to …

In the second of a series, Kim Brotherson, Pharmacy 777 Managing Director, discusses five crucial objectives for the 7CPA In the first of this series, we looked at the scene …

The Government’s current narrow focus on 60-day dispensing and the $1 discount is doing little to ease fears that universal access to medicines is under threat from its determination to …